Researchers
Patient-Powered Mobile Biospecimen Collection
Procure Human Biospecimens Prospectively
Having confidence in your results requires access to clinically relevant biospecimens and comprehensive datasets from diverse donors to develop meaningful biomarkers. Specific inclusion and exclusion criteria, hard-to-reach patient populations, and study design complexity increasingly complicate biospecimen procurement for research.
By leveraging an engaging direct-to-patient approach, coupled with on-demand specimen procurement and comprehensive donor data collection, you’ll enlist even the hardest-to-reach populations. Our simple, fully integrated service solution has you covered from recruitment to sample delivery, including same-day delivery.
1
Recruitment
& Screening
2
Informed Consent
3
@Home Sample
& Data Collection
4
Delivery
1
Recruitment
& Screening
2
Informed Consent
3
@Home Sample
& Data Collection
4
Delivery
Human biospecimens collected in the patient's home
Our experienced and professional mobile phlebotomy team specializes in minimally invasive specimen collection and in-home centrifugation. You can specify one biospecimen type or simultaneously collect multiple matrices (e.g., serum and skin tapes).
Blood-Derived Biofluids and Products
Non-Blood-Derived Biofluids
- Nasal mucosa
- Non-induced sputum
- Saliva
- Semen
- Stool
- Urine
Integumentary Tissues
- Fingernails
- Hair
- Noninvasive Skin Tapes
Obtain biospecimens according to your study protocol through our custom biorepository services, including peripheral blood mononuclear cell (PBMC) isolation, HLA typing, comprehensive clinical testing, and temperature-controlled shipping.
Get Fast, Relevant Healthy Specimens with an Onsite Collection Program
We understand that your ability to produce reliable results is contingent on the quality of samples you receive—particularly for molecules with short half-lives in circulation. Our full-service healthy control programs give you a convenient and customizable way to collect the freshest possible healthy control biospecimens.
Onsite programs allow employees to participate as healthy controls with our blood donor program, whereas remote same-day collection and delivery are available within a 4-hour radius of research sites in select geographical locations.
Community Access: streamline procurement in one or several disease states
Community Access provides repeat access to a specified patient community across your organization through a customizable blanket agreement. Streamlining the fulfillment of multiple translational biospecimen studies in specific patient populations cuts costs and accelerates results.
Why Sanguine
Prospective biospecimen collection enables custom study design and enhanced participant recruitment. You’ll get more accurate data points per sample, increased study design flexibility, and an expedited time to completion.
Same-day specimen procurement and delivery
Nationwide patient member community to meet complex inclusion/exclusion criteria
Medical record-verified eligibility and pre-screening
Access to electronic medical records, health histories, patient-reported datasets
Custom pre-analytical processing, biomarker, storage, & delivery services
Connect with Patients in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 70,000 total members ready to advance science and medicine for the conditions that impact their lives.
Enhance Biomarker Development with Longitudinal Sampling
Sanguine’s commitment to patient engagement translates into study participants who are 95% recallable. The ability to collect multiple biospecimens in-home and over time supports the elucidation and validation of biomarkers that more closely resemble the real-world experience of patients. Furthermore, repeat measures statistics enable more data signals with fewer study participants, reducing costs and timelines.
Get Samples for My Research
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, and International Conference on Harmonization (ICH).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.